Skip to main content
. 2017 Sep 5;72(12):3349–3352. doi: 10.1093/jac/dkx296

Table 1.

Impact of rifampicin on AG susceptibility of CF lung isolates of P. aeruginosaa

Strainb MIC (mg/L)c
TOB
AMK
GEN
NEO
−RIF +RIFd −RIF +RIF −RIF +RIF −RIF +RIF
K3518 32 8 (4) 128 64 (2) 256 64 (4) 512 256 (2)
K3519 32 2 (16) 128 8 (16) 128 4 (32) 256 64 (4)
K3520 16 8 (2) 32 64 (0.5) 64 64 (1) 256 64 (4)
K3522 16 4 (4) 32 16 (2) 32 8 (4) 1024 8 (128)
K3524 128 16 (8) 512 256 (2) 512 128 (4) 1024 64 (16)
K3525 16 16 (1) 1 2 (0.5) 64 64 (1) 32 16 (2)
K3526 1 2 (0.5) 8 8 (1) 8 8 (1) 512 64 (8)
K3527 4 2 (2) 64 8 (8) 64 16 (4) 512 64 (8)
K3528 4 1 (4) 16 4 (4) 16 2 (8) 256 16 (16)
K3529 32 4 (8) 4 4 (1) 512 32 (16) 32 1 (32)
K3530 16 16 (1) 64 64 (1) 64 64 (1) 1024 16 (64)
K3531 32 8 (4) 64 32 (2) 128 32 (4) 1024 128 (8)
K3532 16 16 (1) 32 32 (1) 16 32 (0.5) 256 64 (4)
K3533 16 16 (1) 128 128 (1) 64 64 (1) 1024 8 (128)
K3534 4 4 (1) 32 8 (4) 16 8 (2) 512 8 (64)
K3535 16 16 (1) 64 32 (2) 128 32 (4) 128 32 (4)
K3536 32 32 (1) 256 256 (1) 128 64 (2) 1024 64 (16)
K3537 16 8 (2) 32 16 (2) 64 32 (2) 512 64 (8)
K3538 64 8 (8) 512 128 (4) 512 64 (8) 512 4 (128)
K3539 16 8 (2) 128 32 (4) 256 64 (4) 2048 128 (16)
K3540 8 8 (1) 64 64 (1) 64 32 (2) 1024 16 (64)
K3641 32 16 (2) 32 32 (1) 64 64 (1) 128 128 (1)
K3642 64 16 (4) 256 64 (4) 128 32 (4) 256 128 (2)
K3645 16 4 (4) 64 16 (4) 64 16 (4) 256 2 (128)
K3647 16 8 (2) 64 16 (4) 64 32 (2) 32 8 (4)
K3649 16 8 (2) 64 32 (2) 64 8 (8) 512 32 (16)
K3651 16 8 (2) 64 64 (1) 64 32 (2) 128 64 (2)
K3653 32 8 (4) 128 32 (4) 64 32 (2) 256 64 (4)
K3656 64 32 (2) 128 64 (2) 128 64 (2) 512 128 (4)
K3657 64 32 (2) 256 64 (4) 256 64 (4) 512 256 (2)
K3659 128 32 (4) 512 64 (8) 256 32 (8) 512 64 (8)
K3660 128 64 (2) 512 256 (2) 256 256 (1) 512 256 (2)
K3665 16 4 (4) 128 32 (4) 128 16 (8) 1024 8 (128)
K3667 16 4 (4) 64 32 (2) 64 64 (1) 512 32 (16)
K3669 32 8 (4) 128 64 (2) 128 64 (2) 256 8 (32)
K3673 512 256 (2) 4096 512 (8) ≥4096 256 (≥16) 512 512 (1)
K3675 64 16 (4) 256 128 (2) 256 64 (4) 2048 256 (8)
K3677 8 4 (2) 32 8 (4) 32 16 (2) 256 16 (16)
K3679 32 4 (8) 128 16 (8) 128 16 (8) 512 8 (64)
K3681 128 8 (16) 256 16 (16) 256 16 (16) 512 4 (128)
K3683 128 16 (8) 256 32 (8) 256 32 (8) 1024 128 (8)
K3685 1024 128 (8) 1024 128 (8) 2048 256 (8) 512 256 (2)
K3687 128 8 (16) 512 32 (16) 512 16 (32) 1024 128 (8)
K3689 16 4 (4) 128 16 (8) 16 8 (2) 256 16 (16)
K3691 16 8 (2) 128 32 (4) 64 32 (2) 256 64 (4)

TOB, tobramycin; AMK, amikacin; GEN, gentamicin; NEO, neomycin; RIF, rifampicin.

a

Susceptibility of P. aeruginosa CF isolates to the indicated AGs was assessed in the absence (−) and presence (+) of rifampicin at ½ MIC.

b

Strains where rifampicin enhanced susceptibility to all tested AGs ≥4-fold are underlined. Strains where rifampicin enhanced susceptibility to all AGs except neomycin ≥4-fold are italicized.

c

Fold change in MIC of the indicated AG in the presence versus absence of rifampicin is indicated in parentheses. MIC values ≥4-fold lower in the presence of rifampicin are in bold.

d

Rifampicin was included in AG susceptibility assays at 2 mg/L (K3526), 4 mg/L (K3528, K3532, K3536, K3641, K3656, K3667), 8 mg/L (K3518, K3519, K3522, K3525, K3529, K3530, K3531, K3533, K3534, K3535, K3537, K3538, K3539, K3540, K3651, K3653, K3657, K3660, K3669, K3675, K3677, K3679, K3685, K3687, K3691) or 16 mg/L (K3520, K3524, K3527, K3642, K3645, K3647, K3649, K3659, K3665, K3673, K3681, K3683, K3689).